RxElite, Inc.
RXEI · OTC
9/30/2008 | 6/30/2008 | 3/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $1 | $3 | $1 | $10 |
| + Debt | $7 | $6 | $1 | $1 |
| Enterprise Value | $6 | $3 | $0 | -$9 |
| Revenue | $3 | $3 | $3 | $1 |
| % Growth | 8.4% | 0.2% | 155.2% | – |
| Gross Profit | $0 | $1 | $0 | -$0 |
| % Margin | 9.4% | 16.7% | 11.9% | -14.4% |
| EBITDA | $5 | -$3 | $2 | -$0 |
| % Margin | 166% | -83.6% | 75.6% | -15.9% |
| Net Income | -$11 | -$6 | -$7 | -$5 |
| % Margin | -336.6% | -212.6% | -234.7% | -411.8% |
| EPS Diluted | -0.094 | -0.055 | -0.061 | -0.055 |
| % Growth | -71.4% | 10.3% | -11.9% | – |
| Operating Cash Flow | -$1 | -$2 | -$2 | $1 |
| Capital Expenditures | $0 | $0 | $0 | -$1 |
| Free Cash Flow | -$1 | -$2 | -$2 | -$0 |